Therapeutically, the inhibition of RIPK3 or RIPK1 exhibited anti-inflammatory effects in animal disease models, suggesting that the inhibitors of these kinases may have a therapeutic potential to treat inflammatory injuries (99). This evidence concerns the gene RIPK1 and non-human animal disease.